ETFIQData as of Nov 18, 2026. · etfiq.com/funds/eqwl

EQWL Fact Sheet: Invesco S&P 100 Equal Weight ETF

Share
$128.62
close, Nov 18, 2026

Over the year to Nov 18, 2026, EQWL returned +14.3% in total and charged 0.25% a year.

1-year total return
+14.3%
to Nov 18, 2026
Expense ratio
0.25%
a year
Net assets
$2.7bn
on Nov 17, 2026
Net flow, last 5 trading days
+$15.9m
daily basis to Nov 17, 2026

Growth of $10,000, 1 year

EQWL $11,427 +14.3% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month−1.8%
3 months−4.6%
Year to date+10.2%
1 year+14.3%
3 years+66.0%
5 years+67.1%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
Accenture PLC1.38%
Eli Lilly & Co1.28%
Costco Wholesale Corp1.25%
Intuitive Surgical Inc1.24%
Walmart Inc1.23%
Procter & Gamble Co1.22%
Amgen Inc1.19%
Gilead Sciences Inc1.19%
AbbVie Inc1.19%
Berkshire Hathaway Inc1.18%

EQWL top ten by weight, 12.3% of the fund, of its 103 equity positions, from the holdings published by its issuer for Nov 17, 2026.

Facts

Equity fund · Tracks the S&P 100 Equal Weight Index · First traded Dec 1, 2006 · Benchmark Its own holdings, as of Nov 17, 2026

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, EQWL Fact Sheet: Invesco S&P 100 Equal Weight ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/eqwl/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/eqwl.